PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Levothyroxine sodium
Presentation Product Chemical substance Chapter Items dispensed
Levothyroxine sodium 750micrograms/5ml oral liquid
0602010V0AAELEL
Levothyroxine sodium Levothyroxine sodium Endocrine System No data available
Levothyroxine sodium 75microgram capsules
0602010V0AAAEAE
Levothyroxine sodium Levothyroxine sodium Endocrine System No data available
Levothyroxine sodium 75micrograms/5ml oral liquid
0602010V0AACVCV
Levothyroxine sodium Levothyroxine sodium Endocrine System No data available
Levothyroxine sodium 80micrograms/5ml oral liquid
0602010V0AAEVEV
Levothyroxine sodium Levothyroxine sodium Endocrine System No data available
Levothyroxine sodium 87.5micrograms/5ml oral liquid
0602010V0AAFXFX
Levothyroxine sodium Levothyroxine sodium Endocrine System No data available
Levothyroxine sodium 90micrograms/5ml oral liquid
0602010V0AAEIEI
Levothyroxine sodium Levothyroxine sodium Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.